Younger adults with colon cancer tend to be diagnosed at a later stage and have more aggressive types of tumors.
Should RSV Vaccination Expand to Younger High-Risk Groups?
Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and middle-age adults, CDC advisors have not yet